Second Annual Celgene Innovation Impact Awards Announces Three Winners

Celgene is pleased to announce the 2014 Innovation Impact award winners: Cancer101, LUNGevity Foundation and the Pancreatic Cancer Action Network.  Now in its second year, the Celgene Innovation Impact award program is a natural outgrowth of the company’s commitment to innovation.  The award program recognizes and honors patient and professional organizations that have shown excellence in crafting novel solutions that creatively meet patient, caregiver and/or healthcare providers’ needs in hematology, oncology and immune-inflammatory conditions.

Mobile apps, fitness programs, peer-to-peer networking, an in-person “helpline,” were among the innovative projects and ideas submitted by the twenty-four organizations participating in this year’s program.

innovation Impact logoWinners were selected by a five-person judging panel that included: a patient, a policy researcher, a patient advocate, a healthcare policy consultant and a Celgene representative. Winning organizations will receive an award toward their initiative.

The 2014 winning applications are:

  • Cancer101’s Prescription to Learn Platform™ is designed to help navigate patients and caregivers through the information overload they are often confronted with throughout the cancer journey.
  • LUNGevity Foundation proposed to initiate, design, and execute a study of the benefit and risk assessment that patients undergo when deciding upon the care and/or treatment they wish to receive following a lung cancer diagnosis.
  • Pancreatic Cancer Action Network’s Know Your Tumor initiative is designed to increase the number of pancreatic cancer patients participating in clinical trials by empowering them with information that assists with treatment decisions.

beetsch.joelThis year’s competition was fierce and all of the projects and ideas submitted are worthy of support,” shared Vice President, Patient Advocacy, Joel Beetsch, PhD.  “Our 2014 winners are helping to put a spotlight on the importance of patients receiving the right information at the right time to make decisions that are right for them.  They are also elevating the role of the patient voice in the research process.  This is no longer something nice to do; it’s imperative that Celgene incorporate the patient voice throughout the entire development continuum of medical innovation and by working with these organizations on their initiatives, we expect this will happen.

To learn more about Celgene’s Innovation Impact award program, visit the website at www.innovationimpact.com